{"id":"NCT01363479","sponsor":"Helsinn Healthcare SA","briefTitle":"An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting","officialTitle":"Single-dose, Multicenter, Randomized, Double-blind, Double-dummy, Parallel Group Study to Assess the Efficacy and Safety of Oral Palonosetron 0.50 mg Compared to I.V. Palonosetron 0.25 mg Administered With Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Cisplatin-based Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07","primaryCompletion":"2012-11","completion":"2012-11","firstPosted":"2011-06-01","resultsPosted":"2014-11-17","lastUpdate":"2021-09-22"},"enrollment":743,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Chemotherapy-Induced Nausea and Vomiting"],"interventions":[{"type":"DRUG","name":"Oral palonosetron","otherNames":[]},{"type":"DRUG","name":"I.V. palonosetron","otherNames":[]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]}],"arms":[{"label":"Oral palonosteron plus dexamethasone","type":"EXPERIMENTAL"},{"label":"I.V. palonosetron plus dexamethasone","type":"ACTIVE_COMPARATOR"}],"summary":"PALO-10-01 is a clinical study assessing efficacy and safety of a single oral dose of palonosetron compared to a single intravenous dose of palonosetron (Aloxi, an antiemetic drug), both given with oral dexamethasone. The objective of the study is to demonstrate that oral palonosetron 0.50 mg is as effective as (non-inferior to) palonosetron IV 0.25 mg to prevent nausea and vomiting induced by highly emetogenic cancer chemotherapy in the 0-24 hours after administration of a single cycle of highly emetogenic chemotherapy.","primaryOutcome":{"measure":"Percentage of Patients With Complete Response (CR) Defined as no Emesis, no Rescue Medication","timeFrame":"0-24 hours","effectByArm":[{"arm":"Oral Palonosteron Plus Dexamethasone","deltaMin":89.4,"sd":null},{"arm":"I.V. Palonosetron Plus Dexamethasone","deltaMin":86.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":13},"locations":{"siteCount":79,"countries":["United States","Argentina","Bulgaria","Croatia","Germany","Hungary","India","Italy","Poland","Romania","Russia","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":370},"commonTop":["Investigations","Asthenia","Neutropenia","Constipation","Respiratory, thoracic and mediastinal disorder"]}}